Coronary artery bypass grafting in DES Era

Annals of Thoracic and Cardiovascular Surgery

Volumn 13, Issue 1, 2007, Pages 5-8

  Tashiro, Tadashi ^a   Morishige, Noritsugu ^a   Iwahashi, Hidehiko ^a   Hayashida, Yoshio ^a   Takeuchi, Kazuma ^a   Ito, Nobuhisa ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Complete revascularization; Coronary artery bypass grafting; Drug eluting stent; Off pump coronary artery bypass grafting

Indexed keywords

CARDIOVASCULAR AGENT;

BLOOD VESSEL TRANSPLANTATION; CORONARY ARTERY BYPASS GRAFT; HEART MUSCLE ISCHEMIA; HUMAN; RESTENOSIS; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; HUMANS; MYOCARDIAL ISCHEMIA; STENTS;

EID: 34447303591     PISSN: 13411098     EISSN: 21861005     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004; 78: 2005-14.
2. Burfeind WR Jr, Glower DD, Wechsler AS, et al. Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial. Circulation 2004; 110 (11 Suppl 1): II27-35.
3. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
4. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-5.
5. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARIlike patients in northern New England. Circulation 2005; 112 (9 Suppl): I371-6.
6. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352: 2174-83.
7. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761-9.
8. http://www.sts.org/sections/stsnationaldatabase/ publications/executive/article.html
9. Kazui T, Wada H, Fujita H. Thoracic and cardiovascular surgery in Japan during 2003: annual report by The Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg 2005; 53: 517-36.
10. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005; 112: 3306-13.
11. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
12. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005; 294: 1215-23.
13. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
14. Rodriguez A, Grindfeld L, Fernandez-Pereira C, et al. Multiple vessel stenting in drug eluting stent era: one year follow up of the EARACI III study. Euro Heart J 2005; 26 (Suppl): 410.
15. Herz I, Moshkovitz Y, Hendler A, et al. Revascularization of left anterior descending artery with drug-eluting stents: comparison with off-pump surgery. Ann Thorac Surg 2005; 79: 88-92.
16. Herz I, Moshkovitz Y, Loberman D, et al. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg 2005; 80: 2086-90.
17. Guyton RA. Coronary artery bypass is superior to drugeluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006; 81: 1949-57.
18. Liddicoat JR, De La Torre R, Ho KK, et al. Initial impact of drug-eluting stents on coronary artery bypass graft surgery. Ann Thorac Surg 2006; 81: 1239-42.
19. Sharony R, Bizekis CS, Kanchuger M, et al. Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: a case control study. Circulation 2003; 108 (Suppl 1): II15-20.
20. http://www.med.nihon-u.ac.jp/jacas/result2005.html
21. Desai ND, Pelletier MP, Mallidi HR, et al. Why is offpump coronary surgery uncommon in Canada? Results of a population-based survey of Canadian heart surgeons. Circulation 2004; 110 (11 Suppl 1): II7-12.
22. Racz MJ, Hannan EL, Isom OW, et al. A comparison of short-and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol 2004; 43: 557-64.
23. Caputo M, Reeves BC, Rajkaruna C, et al. Incomplete revascularization during OPCAB surgery is associated with reduced mid-term event-free survival. Ann Thorac Surg 2005; 80: 2141-7.
24. Dewey TM, Herbert MA, Prince SL, et al. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease? Ann Thorac Surg 2006; 81: 591-8.
25. Possati G, Gaudino M, Prati F, et al. Long-term results of the radial artery used for myocardial revascularization. Circulation 2003; 108: 1350-4.
26. Shah PJ, Gordon I, Fuller J, et al. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg 2003; 126: 1972-7.